Ikena Oncology, Inc.IKNANASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR-18.4%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
-18.4%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025100.00%
2024-106.02%
2023-40.08%
2022184.25%
202154.78%
2020-218.76%
201970.56%
20180.00%